Detalhe da pesquisa
1.
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.
J Investig Allergol Clin Immunol
; 32(2): 124-132, 2022 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856595
2.
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.
Clin Exp Dermatol
; 47(3): 561-567, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642965
3.
A cream containing the sap of oat plantlets and mandarin extract soothes the symptoms of rosacea and improves the quality of life of patients.
J Eur Acad Dermatol Venereol
; 36 Suppl 8: 3-11, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796500
4.
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement.
J Eur Acad Dermatol Venereol
; 36(3): 332-350, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910332
5.
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience.
J Eur Acad Dermatol Venereol
; 36(8): 1292-1299, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412683
6.
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Br J Dermatol
; 184(1): 133-140, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119111
7.
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
J Eur Acad Dermatol Venereol
; 35(7): 1485-1492, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660357
8.
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.
J Eur Acad Dermatol Venereol
; 35(4): 958-964, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332697
9.
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families.
Clin Exp Dermatol
; 45(8): 1044-1046, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415864
10.
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study.
Clin Exp Dermatol
; 45(7): 888-890, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365237
11.
Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period.
Clin Exp Dermatol
; 45(7): 848-852, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363583
12.
Comorbidities in pediatric alopecia areata.
J Eur Acad Dermatol Venereol
; 34(12): 2898-2901, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32531131
13.
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.
J Eur Acad Dermatol Venereol
; 34(8): 1815-1821, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119143
14.
A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
Br J Dermatol
; 181(5): 1038-1045, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30829398
15.
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.
Clin Exp Dermatol
; 44(5): e177-e180, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30593710
16.
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.
J Eur Acad Dermatol Venereol
; 33 Suppl 6: 25-27, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535761
17.
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol
; 38(1): e113-e116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611277
18.
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
J Eur Acad Dermatol Venereol
; 33(4): 766-773, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633405
19.
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination.
J Eur Acad Dermatol Venereol
; 37(12): e1369-e1371, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561928
20.
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.
Clin Exp Dermatol
; 47(1): 165-167, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309892